Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Inosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 known ✓ | P27487 | 1/20 | 0.67 |
| ▸ | ADRB2 known ✓ | P07550 | 1/20 | 0.58 |
| ▸ | KCNH2 known ✓ | Q12809 | 1/20 | 0.58 |
| ▸ | SLC29A1 | Q99808 | 4/20 | 0.67 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.67 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.67 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.67 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.67 |
| ▸ | GAPDH | P04406 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.67 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.67 |
| ▸ | STAT6 | P42226 | 1/20 | 0.67 |
| ▸ | PI4KA | P42356 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.67 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Inosine SCHEMBL1331735 | 1.00 | SLC29A1 (0.67) | SLC29A1ADORA1SMN1; SMN2ADORA3DPP4 | |
| Inosine SCHEMBL27486904 | 1.00 | SLC29A1 (0.67) | SLC29A1ADORA1SMN1; SMN2ADORA3DPP4 | |
| Inosine SCHEMBL29898199 | 1.00 | SLC29A1 (0.67) | SLC29A1ADORA1SMN1; SMN2ADORA3DPP4 | |
| Inosine SCHEMBL29941344 | 1.00 | SLC29A1 (0.67) | SLC29A1ADORA1SMN1; SMN2ADORA3DPP4 | |
| Inosine SCHEMBL5365023 | 1.00 | SLC29A1 (0.67) | SLC29A1ADORA1SMN1; SMN2ADORA3DPP4 | |
| Inosine SCHEMBL17824478 | 1.00 | SLC29A1 (0.67) | SLC29A1ADORA1SMN1; SMN2ADORA3DPP4 | |
| Inosine SCHEMBL10622941 | 0.99 | SLC29A1 (0.66) | SLC29A1ADORA1SMN1; SMN2ADORA3DPP4 | |
| Inosine SCHEMBL19436352 | 0.99 | ADORA1 (0.66) | SLC29A1ADORA1SMN1; SMN2ADORA3DPP4 | |
| Inosine SCHEMBL311515 | 0.95 | ADORA1 (0.68) | SLC29A1ADORA1SMN1; SMN2ADORA3DPP4 | |
| Inosine SCHEMBL5905453 | 0.94 | SLC29A1 (0.64) | SLC29A1ADORA1SMN1; SMN2ADORA3DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6047 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | claimed |
| US-20260063623-A1 | METHODS OF ASSESSING METABOLIC FLUX | UNIV MICHIGAN REGENTS (US) | 2026-03-05 | — | — | US | claimed |
| EP-4031214-B1 | INJECTION SYSTEMS | MEIRAGTX OCULAR UK LTD (GB) | 2026-02-18 | — | — | EP | claimed |
| EP-4692364-A1 | METHOD FOR PRODUCING SUBSTANCE | Mitsubishi Chemical Corporation (JP) | 2026-02-11 | — | — | EP | claimed |
| US-20260028656-A1 | METHOD FOR PRODUCING SUBSTANCE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-01-29 | — | — | US | claimed |
| EP-4398740-B1 | MEAT ANALOGUE AND METHOD TO DECREASE THE OFF-FLAVOUR THEREOF | UNILEVER IP HOLDINGS B V (NL) | 2025-11-26 | — | — | EP | claimed |
| US-20250344736-A1 | FAT REDUCTION IN NON-ANIMAL PROTEIN COMPOSITIONS | FIRMENICH SA (CH) | 2025-11-13 | — | — | US | claimed |
| US-20250332162-A1 | INHIBITING PURINE BIOSYNTHESIS TO INCREASE FAVIPIRAVIR POTENCY AGAINST RNA VIRUS INFECTIONS | VIRIOM INC (US) | 2025-10-30 | — | — | US | claimed |
| EP-4602365-A2 | METHODS OF ASSESSING METABOLIC FLUX | The Regents of The University of Michigan (US) | 2025-08-20 | — | — | EP | claimed |
| EP-4593631-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | Mars, Incorporated (US) | 2025-08-06 | — | — | EP | claimed |
| US-5066500-A | Similar to human milk | UNION INDUSTRIAL Y AGRO-GANADERA, S. A. (UNIASA) (ES) | 1991-11-19 | — | — | US | claimed |
| WO-1991005559-A1 | DIAGNOSIS AND TREATMENT OF NEURO-COGNITIVE DISORDERS ASSOCIATED WITH SYSTEMIC IMMUNOLOGICAL MALFUNCTION | HEM RESEARCH, INC. (US) | 1991-05-02 | — | — | WO | claimed |
| US-4994442-A | Administering liquid mixtures of nutrients, nucleosides and/or nucleotides | UNION INDUSTRIAL Y AGRO-GANADERA, S.A. (UNIASA) (ES) | 1991-02-19 | — | — | US | claimed |
| WO-1990014090-A1 | SHORT THERAPEUTIC dsRNA OF DEFINED STRUCTURE | HEM RESEARCH, INC. (US) | 1990-11-29 | — | — | WO | claimed |
| EP-0318326-A2 | Method of removing sterols from edible fats and/or oils and/or fats and/or oils from which sterols have been removed | NEW ZEALAND DAIRY RESEARCH INSTITUTE (NZ) | 1989-05-31 | — | — | EP | claimed |
| EP-0302807-A2 | Food products enriched with nucleosides and/or nucleotides and preparation thereof | PULEVA UNION INDUSTRIAL Y AGRO-GANADERA, S.A. (ES) | 1989-02-08 | — | — | EP | claimed |
| EP-0083261-B1 | THERAPEUTIC COMPOSITION FOR THE TREATMENT OF EYE ACCOMMODATION DISTURBANCES | Laboratoires P.O.S. Société Anonyme dite: (FR) | 1988-04-20 | — | — | EP | claimed |
| US-4459292-A | Therapeutic compositions for the treatment of accommodation problems of the eye and method of using inosine monophosphate | LABORATOIRES POS (FR) | 1984-07-10 | — | — | US | claimed |
| US-4303680-A | AUTOLYSIS, RNA EXTRACTION, ENZYMATIC HYDROLYSIS | AJINOMOTO COMPANY, INCORPORATED (JP) | 1981-12-01 | — | — | US | claimed |
| US-4197323-A | SYNTHETIC MEATS, SPINNING, COAGULATION, COMPRESSION, DIHYDRATION, STERILIZATION | SOCIETE D'ASSISTANCE TECHNIQUE POUR PRODUITS NESTLE S.A. (CH) | 1980-04-08 | — | — | US | claimed |